Cart
sales@molnova.com
NCGC00029283
CAS No. 714240-31-0
NCGC00029283( —— )
Catalog No. M35229 CAS No. 714240-31-0
NCGC00029283 is a potent inhibitor of Werner syndrome helicase-nuclease (WRN), displaying inhibitory activity against WRN helicase with an IC 50 value of 2.3 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 169 | In Stock |
|
| 5MG | 159 | In Stock |
|
| 10MG | 259 | In Stock |
|
| 25MG | 448 | In Stock |
|
| 50MG | 647 | In Stock |
|
| 100MG | 904 | In Stock |
|
| 200MG | 1200 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNCGC00029283
-
NoteResearch use only, not for human use.
-
Brief DescriptionNCGC00029283 is a potent inhibitor of Werner syndrome helicase-nuclease (WRN), displaying inhibitory activity against WRN helicase with an IC 50 value of 2.3 μM.
-
DescriptionNCGC00029283 is a werner syndrome helicase-nuclease (WRN) helicase inhibitor with IC50s of 2.3 μM, 12.5 μM, and 3.4 μM for WRN, BLM and FANCJ helicase, respectively.
-
In VitroNCGC00029283 (0-100 μM; 24-72 h) effectively blocks cell proliferation in U2-OS cells.Cell Proliferation Assay Cell Line:U2-OS cells Concentration:1 μM, 10 μM, 100 μM Incubation Time:24 h, 48 h, 72 h Result:Showed a reduction in U2-OS cell proliferation.
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA/RNA Synthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number714240-31-0
-
Formula Weight337.3
-
Molecular FormulaC18H12FN3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 6.94 mg/mL (20.58 mM; Ultrasonic (<60°C)
-
SMILESCOc1ccc2[nH]c(=O)c(cc2c1)-c1noc(n1)-c1ccc(F)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Joshua A Sommers, et al. A high-throughput screen to identify novel small molecule inhibitors of the Werner Syndrome Helicase-Nuclease (WRN). PLoS One. 2019 Jan 9;14(1):e0210525.?
molnova catalog
related products
-
Cycloheximide
Cycloheximide (Naramycin A, Actidione) is a widely-used protein synthesis inhibitor.
-
DHX9-IN-2
DHX9-IN-2 is an inhibitor targeting ATP-dependent RNA de-helicase A (DHX9) with anticancer and antitumor activity for cancer research.
-
NSAH?
NSAH is a nonnucleoside inhibitor of human ribonucleotide reductase (hRR).with cell-free IC50 of 32 μM and cell-based IC50 of ~250 nM, respectively.A unique nonnucleoside small-molecule hRR inhibitor, naphthyl salicylic acyl hydrazone (NSAH), using virtual screening, binding affinity, inhibition, and cell toxicity assays.?NSAH binds to hRRM1 with an apparent dissociation constant of 37 μM, and steady-state kinetics reveal a competitive mode of inhibition.?
